The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of single versus double hormone receptor positive breast cancer.
 
Josee-Lyne Ethier
No Relationships to Disclose
 
Alberto Ocana
No Relationships to Disclose
 
Maribel Casas
No Relationships to Disclose
 
Maria Sanchez-Arago
No Relationships to Disclose
 
Rosalia Caballero
Patents, Royalties, Other Intellectual Property - NanoString Technologies
 
Alvaro Rodriguez-Lescure
No Relationships to Disclose
 
Amparo Ruiz
No Relationships to Disclose
 
Emilio Alba
No Relationships to Disclose
 
Lourdes Calvo
No Relationships to Disclose
 
Manuel Ruiz
No Relationships to Disclose
 
Ana Santaballa
No Relationships to Disclose
 
Cesar Augusto Rodriguez
No Relationships to Disclose
 
Carmen Crespo
No Relationships to Disclose
 
Manuel Ramos Vazquez
No Relationships to Disclose
 
Jose Manuel Gracia
No Relationships to Disclose
 
Ana Lluch
Speakers' Bureau - Novartis; Pfizer; Roche
 
Isabel Alvarez
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Research Funding - Lilly; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Eva Maria Carrasco
Stock and Other Ownership Interests - Lilly
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb (I); Celgene; Celgene (I); Gilead Sciences; Gilead Sciences (I); Novartis; Novartis (I); Pfizer; Pfizer (I); Roche; Roche (I)
Consulting or Advisory Role - Celgene (I); Gilead Sciences (I)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genomic Health (Inst); Italfarmaco (Inst); NanoString Technologies (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - NanoString Technologies
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb (I); Novartis; Novartis (I); Roche; Roche (I)
 
Eitan Amir
No Relationships to Disclose
 
Miguel Martin
Consulting or Advisory Role - Amgen; Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst)